Alpha-Maven Private Equity Dashboard:

Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

1w ago Private Equity privateequitywire Views: 50

Amulet Capital Partners raises second fund with USD650m of capital commitments Submitted 15/09/2021 - 8:33am Amulet Capital Partners (Amulet), a middle-market private equity investment firm based in Greenwich, Connecticut, focused exclusively on the healthcare sector, has closed its second fund, Amulet Capital Partners II. The Fund, executed as a mostly virtual process, was oversubscribed and closed with in excess of USD650 million in capital commitments, exceeding the Fund’s target of USD500 million. The firm’s thematic approach to healthcare investing, focusing on complex and advantaged situations as well as a consistent approach to driving value post-acquisition, attracted strong support from new and existing investors. The Fund has already completed two investments, US Fertility, the largest physician practice management company serving the fertility market in the US, and SSI Strategy, a leading consulting firm focused on providing medical affairs and clinical development support to emerging biotech companies. This fundraise brings Amulet’s total regulatory capital under management to over USD1.3 billion. “We are pleased to announce the closing for Fund II and are grateful for the overwhelming support we received from our existing investors as well as from a large group of new institutional limited partners,” says Ramsey Frank, Partner and Co-Founder of Amulet. “We believe our impressive track record, deep domain knowledge and extensive network of healthcare industry relationships will enable us to identify attractive investment targets and bring new growth opportunities to each of the companies with which we partner. We are excited and optimistic about the market prospects for the Fund.” Capstone Partners acted as Amulet’s placement agent, and Kirkland & Ellis LLP acted as legal counsel. Like this article? Sign up to our free newsletter Author Profile Related Topics Funds Launches & Fundraising -

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.